Supreme Court Upholds Access to Abortion Pill for Now

Summary

In a significant 7-2 decision, the U.S. Supreme Court has temporarily preserved nationwide access to mifepristone, a key medication used for abortions, for at least another year to eighteen months. This ruling allows the drug to be sold even in states that have banned abortion, while the legal challenge makes its way through the appeals process. The decision suggests that a majority of the justices may ultimately rule in favor of allowing the drug's availability, contradicting the dissenting opinions of Justices Alito and Thomas. They argued the drug companies are a "criminal enterprise" motivated by profit and seeking to undermine the Supreme Court's earlier decision in Dobbs v. Jackson, which overturned Roe v. Wade. This latest development follows a previous attempt to ban the drug by a Texas district judge and a nationwide block attempted by the Fifth Circuit Court of Appeals. The FDA has stated mifepristone is safer than aspirin, and medication abortion accounts for nearly 60% of abortions in the U.S. This temporary preservation of access is viewed as a positive sign by reproductive rights advocates, but the ultimate ruling remains pending.